{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:51:40Z","timestamp":1792068700709,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess the prognostic impact of sepsis-induced coagulopathy (SIC) on mortality and clinical outcomes in patients with sepsis admitted to the intensive care unit (ICU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 1,305 adult patients with sepsis admitted to a tertiary pulmonary ICU between January 2016 and May 2025. SIC was defined using the International Society on Thrombosis and Haemostasis (ISTH) criteria, based on platelet (PLT) count, prothrombin time\/international normalized ratio (PT\/INR), and total Sequential Organ Failure Assessment (SOFA) score components. The primary outcome was in-hospital mortality, and secondary outcomes included vasopressor requirement, escalation to second-line vasopressor therapy, invasive mechanical ventilation (IMV), and continuous renal replacement therapy (CRRT). Multivariable logistic regression and receiver operating characteristic (ROC) analyses were conducted to assess the prognostic value of SIC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of SIC was 19.2%. Patients with SIC had significantly higher in-hospital mortality than those without SIC (79.3% vs. 60.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Vasopressor use and escalation to second-line vasopressor therapy were more frequent in the SIC-positive group (98.0% vs. 92.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001; 45.8% vs. 31.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). In multivariable analyses, both SIC positivity (OR: 2.172, 95% CI: 1.528\u20133.087,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and the SIC score (OR: 1.324, 95% CI: 1.175\u20131.492,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) were independently associated with mortality. ROC analysis showed that the SIC score had moderate discriminative performance for predicting mortality (AUC: 0.619, 95% CI: 0.588\u20130.649,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), with an SIC score\u2009\u2265\u20094 identified as the clinically interpreted threshold.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SIC was independently associated with higher in-hospital mortality and greater need for vasopressor support in critically ill patients with sepsis. These findings suggest that SIC may provide complementary prognostic information when interpreted alongside established severity assessment tools; however, prospective studies are needed to clarify its clinical relevance and potential role in patient management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-026-04104-3","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:13:09Z","timestamp":1784383989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic impact of sepsis-induced coagulopathy on mortality and clinical outcomes in ICU patients"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-342X","authenticated-orcid":false,"given":"Ay\u015fe","family":"\u00c7apar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2776-740X","authenticated-orcid":false,"given":"Derya","family":"\u00d6zyi\u011fito\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0492-403X","authenticated-orcid":false,"given":"Cemre","family":"Abac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-6508","authenticated-orcid":false,"given":"\u015eeyma","family":"Ba\u015fl\u0131lar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"2","key":"4104_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/life13020350","volume":"13","author":"AG Tsantes","year":"2023","unstructured":"Tsantes AG, Parastatidou S, Tsantes EA, Bonova E, Tsante KA, Mantzios PG, et al. Sepsis-induced coagulopathy: an update on pathophysiology, biomarkers, and current guidelines. Life. 2023;13(2):350.","journal-title":"Life"},{"issue":"23","key":"4104_CR2","doi-asserted-by":"publisher","first-page":"e42709","DOI":"10.1097\/MD.0000000000042709","volume":"104","author":"R Tan","year":"2025","unstructured":"Tan R, Ge C, Yang Z, Guo H, Li Z, Han X, et al. Prediction of poor prognosis in patients with sepsis-induced coagulopathy. Medicine. 2025;104(23):e42709.","journal-title":"Medicine"},{"key":"4104_CR3","doi-asserted-by":"crossref","unstructured":"Man C, An Y, Wang G-X, Mao E-Q, Ma L. Recent advances in pathogenesis and anticoagulation treatment of sepsis-induced coagulopathy. J Inflamm Res. 2025:737\u201350.","DOI":"10.2147\/JIR.S495223"},{"issue":"1","key":"4104_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13613-024-01380-5","volume":"14","author":"T Iba","year":"2024","unstructured":"Iba T, Helms J, Levy JH. Sepsis-induced coagulopathy (SIC) in the management of sepsis. Ann Intensiv Care. 2024;14(1):148.","journal-title":"Ann Intensiv Care"},{"issue":"12","key":"4104_CR5","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1016\/j.jtha.2023.05.028","volume":"21","author":"T Iba","year":"2023","unstructured":"Iba T, Helms J, Neal MD, Levy JH. Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation. J Thromb Haemost. 2023;21(12):3360\u201370.","journal-title":"J Thromb Haemost"},{"issue":"12","key":"4104_CR6","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1111\/jth.15500","volume":"19","author":"L Xiang","year":"2021","unstructured":"Xiang L, Ren H, Wang Y, Zhang J, Qian J, Li B, et al. Clinical value of pediatric sepsis-induced coagulopathy score in diagnosis of sepsis\u2010induced coagulopathy and prognosis in children. J Thromb Haemost. 2021;19(12):2930\u20137.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"4104_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jtha.2022.10.022","volume":"21","author":"T Iba","year":"2023","unstructured":"Iba T, Levi M, Thachil J, Helms J, Scarlatescu E, Levy JH. Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. J Thromb Haemost. 2023;21(1):145\u201353.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"4104_CR8","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/biomedicines13112658","volume":"13","author":"M Stoian","year":"2025","unstructured":"Stoian M, Azamfirei L, St\u00eengaciu AC, Negulici L-M, V\u0103sie\u0219iu AM, Manea A, et al. Early diagnostic markers and risk stratification in sepsis: Prognostic value of neutrophil-to-lymphocyte ratio, platelets, and the carmeli score. Biomedicines. 2025;13(11):2658.","journal-title":"Biomedicines"},{"issue":"1","key":"4104_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12879-024-09154-x","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Liu H, Wang N, Wang F, Shang N, Guo S, et al. Persistent high sepsis-induced coagulopathy and sequential organ failure assessment scores can predict the 28-day mortality of patients with sepsis: A prospective study. BMC Infect Dis. 2024;24(1):282.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"4104_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.22514\/sv.2024.069","volume":"20","author":"G Tullo","year":"2024","unstructured":"Tullo G, Covino M, Carbone L, Dico FL, Corsini G, Piccioni A, et al. Sepsis-induced coagulopathy (SIC) score is an independent predictor of mortality and overt-disseminated intravascular coagulation in emergency department patients with sepsis. Signa Vitae. 2024;20(6):33\u201343.","journal-title":"Signa Vitae"},{"issue":"1","key":"4104_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","volume":"24","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):360.","journal-title":"Crit Care"},{"issue":"11","key":"4104_CR12","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"issue":"1","key":"4104_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13613-022-01093-7","volume":"13","author":"T Schmoch","year":"2023","unstructured":"Schmoch T, M\u00f6hnle P, Weigand MA, Briegel J, Bauer M, Bloos F, et al. The prevalence of sepsis-induced coagulopathy in patients with sepsis\u2013a secondary analysis of two German multicenter randomized controlled trials. Ann Intensiv Care. 2023;13(1):3.","journal-title":"Ann Intensiv Care"},{"issue":"2","key":"4104_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12185-021-03152-4","volume":"114","author":"C Tanaka","year":"2021","unstructured":"Tanaka C, Tagami T, Kudo S, Takehara A, Fukuda R, Nakayama F, et al. Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan. Int J Hematol. 2021;114(2):164\u201371.","journal-title":"Int J Hematol"},{"issue":"11","key":"4104_CR15","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17(11):1989\u201394.","journal-title":"J Thromb Haemost"},{"issue":"13","key":"4104_CR16","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.3390\/jcm14134483","volume":"14","author":"G Turcato","year":"2025","unstructured":"Turcato G, Zaboli A, Lucente F, Filippi L, Maggi M, Brigiari G, et al. Sepsis-induced coagulopathy and hypoalbuminemia: endothelial damage as common pathway and clinical implications on mortality and transfusion risk. J Clin Med. 2025;14(13):4483.","journal-title":"J Clin Med"},{"issue":"1","key":"4104_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12879-025-10972-w","volume":"25","author":"J-Y Yang","year":"2025","unstructured":"Yang J-Y, Li L-L, Fu S-Z. Association analysis of sepsis progression to sepsis-induced coagulopathy: a study based on the MIMIC-IV database. BMC Infect Dis. 2025;25(1):573.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4104_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13613-025-01434-2","volume":"15","author":"A Curtiaud","year":"2025","unstructured":"Curtiaud A, Iba T, Angles-Cano E, Meziani F, Helms J. Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications. Ann Intensiv Care. 2025;15(1):12.","journal-title":"Ann Intensiv Care"},{"key":"4104_CR19","doi-asserted-by":"publisher","first-page":"107602962412831","DOI":"10.1177\/10760296241283166","volume":"30","author":"J-J Cheng","year":"2024","unstructured":"Cheng J-J, Liufu R, Zhuang J, Chen M-Y. Risk factors of sepsis-associated thrombocytopenia among patients with sepsis induced coagulopathy. Clin Appl Thromb Hemost. 2024;30:10760296241283166.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9","key":"4104_CR20","doi-asserted-by":"publisher","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ open. 2017;7(9):e017046.","journal-title":"BMJ open"},{"issue":"04","key":"4104_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1055\/s-0040-1718736","volume":"121","author":"WK Jhang","year":"2021","unstructured":"Jhang WK, Park SJ. Evaluation of sepsis-induced coagulopathy in critically ill pediatric patients with septic shock. Thromb Haemost. 2021;121(04):457\u201363.","journal-title":"Thromb Haemost"},{"issue":"3","key":"4104_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ams2.411","volume":"6","author":"T Iba","year":"2019","unstructured":"Iba T, Umemura Y, Watanabe E, Wada T, Hayashida K, Kushimoto S, et al. Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy. Acute Med Surg. 2019;6(3):223\u201332.","journal-title":"Acute Med Surg"},{"issue":"1","key":"4104_CR23","doi-asserted-by":"publisher","first-page":"15223","DOI":"10.1038\/s41598-023-42352-2","volume":"13","author":"X Jiang","year":"2023","unstructured":"Jiang X, Zhang C, Pan Y, Cheng X, Zhang W. Effects of C-reactive protein trajectories of critically ill patients with sepsis on in-hospital mortality rate. Sci Rep. 2023;13(1):15223.","journal-title":"Sci Rep"},{"key":"4104_CR24","doi-asserted-by":"publisher","first-page":"107602962312192","DOI":"10.1177\/10760296231219249","volume":"29","author":"R Liufu","year":"2023","unstructured":"Liufu R, Chen Y, Wan X-X, Liu R-T, Jiang W, Wang C, et al. Sepsis-induced coagulopathy: The different prognosis in severe pneumonia and bacteremia infection patients. Clin Appl Thromb Hemost. 2023;29:10760296231219249.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"4104_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1213\/ANE.0000000000006888","volume":"138","author":"B Williams","year":"2024","unstructured":"Williams B, Zou L, Pittet J-F, Chao W. Sepsis-induced coagulopathy: a comprehensive narrative review of pathophysiology, clinical presentation, diagnosis, and management strategies. Anesth Analgesia. 2024;138(4):696\u2013711.","journal-title":"Anesth Analgesia"},{"key":"4104_CR26","doi-asserted-by":"publisher","first-page":"1173893","DOI":"10.3389\/fphar.2023.1173893","volume":"14","author":"J-J Huang","year":"2023","unstructured":"Huang J-J, Zou Z-Y, Zhou Z-P, Liu Y, Yang Z-J, Zhang J-J, et al. Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy. Front Pharmacol. 2023;14:1173893.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4104_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/jcm8050728","volume":"8","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Raj A, Warkentin TE. Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Clin Med. 2019;8(5):728.","journal-title":"J Clin Med"},{"issue":"11","key":"4104_CR28","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/biom15111621","volume":"15","author":"M Stoian","year":"2025","unstructured":"Stoian M, Azamfirei L, Bandila SR, Stoian A, Bab\u0103 D-F, B\u0103nescu C. Circulating micrornas and plasma gelsolin as biomarkers of sepsis: Molecular insights and prospects for precision medicine. Biomolecules. 2025;15(11):1621.","journal-title":"Biomolecules"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-026-04104-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04104-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04104-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:17:51Z","timestamp":1792066671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-026-04104-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4104"],"URL":"https:\/\/doi.org\/10.1186\/s12871-026-04104-3","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol received approval from the Non-Interventional Clinical Research Ethics Committee at Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital (date:15.05.2025, protocol code: 2024-55). Because of the retrospective design, informed consent was waived. The study was carried out following the principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"620"}}